Epidermal growth factor induces adult human islet cell dedifferentiation

    1. Lawrence Rosenberg1,2,3
    1. 1Department of Surgery, McGill University, Montreal, Quebec, Canada
      2Centre for Pancreatic Diseases, McGill University Health Centre, Montreal, Quebec, Canada
      3Jewish General Hospital, Montreal, Quebec, Canada
    1. (Correspondence should be addressed to L Rosenberg at Jewish General Hospital; Email: lawrence.rosenberg{at}mcgill.ca)

    Abstract

    Given the inherent therapeutic potential of the morphogenetic plasticity of adult human islets, the identification of factors controlling their cellular differentiation is of interest. The epidermal growth factor (EGF) family has been identified previously in the context of pancreatic organogenesis. We examined the role of EGF in an in vitro model whereby adult human islets are embedded in a collagen gel and dedifferentiated into duct-like epithelial structures (DLS). We demonstrated that DLS formation was EGF dependent, while residual DLS formation in the absence of added EGF was abrogated by EGF receptor inhibitor treatment. With respect to signaling, EGF administration led to an increase in c-Jun NH2-terminal kinase (JNK) phosphorylation early in DLS formation and in AKT and extracellular signal-regulated kinase (ERK) phosphorylation late in the process of DLS formation, concomitant with the increased proliferation of dedifferentiated cells. In the absence of EGF, these phosphorylation changes are not seen and the typical increase in DLS epithelial cell proliferation seen after 10 days in culture is attenuated. Thus, in our model, EGF is necessary for islet cell dedifferentiation, playing an important role in both the onset of DLS formation (through JNK) and in the proliferation of these dedifferentiated cells (through AKT and ERK).

    • Received in final form 24 August 2011
    • Accepted 20 September 2011
    • Made available online as an Accepted Preprint 20 September 2011
    | Table of Contents